VASOMOTOR SYMPTOMS AS AN EARLY MARKER OF CARDIOMETABOLIC RISK IN MENOPAUSAL WOMEN

Lagiya Abdullaeva; Sitora Abduvalieva

Authors

Lagiya Abdullaeva Author
Sitora Abduvalieva Author

Abstract

Vasomotor symptoms (VMS), including hot flashes and night sweats, are the most common manifestations of menopausal syndrome. Recent evidence suggests that VMS may be associated with an increased risk of cardiometabolic disorders. The aim of this study was to evaluate the clinical significance of vasomotor symptoms in the early detection of cardiometabolic risk in perimenopausal and postmenopausal women. A cross-sectional study was conducted involving 120 women aged 45–60 years. Participants were divided into groups based on the presence and severity of VMS. Cardiometabolic parameters, including body mass index (BMI), blood pressure, lipid profile, and fasting glucose levels, were assessed. The results showed a significant association between moderate-to-severe VMS and elevated cardiometabolic risk factors. Women with pronounced VMS had higher BMI, increased systolic blood pressure, and adverse lipid profiles. These findings suggest that VMS may serve as an early clinical marker of cardiometabolic risk, highlighting the importance of timely screening and preventive strategies.

References

1. Freeman EW. Associations of depression with the transition to menopause. Menopause. 2010;17(4):823–827.

2. Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation. Obstet Gynecol Clin North Am. 2011;38(3):489–501.

3. Muka T, Oliver-Williams C, Kunutsor S, Laven JSE, Fauser BCJM, Chowdhury R, et al. Association of vasomotor symptoms and risk of cardiovascular disease. Menopause. 2016;23(2):149–158.

4. El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause transition and cardiovascular disease risk. Circulation. 2020;142(25):e506–e532.

5. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–539.

6. Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrinol Metab Clin North Am. 2015;44(3):497–515.

7.

8. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease. Circulation. 2008;118(12):1234–1240.

9. Herber-Gast GCM, Mishra GD. Early severe vasomotor menopausal symptoms and risk of cardiovascular disease. Menopause. 2018;25(4):414–420.

10. Zhu D, Chung HF, Pandeya N, Dobson AJ, Cade JE, Greenwood DC, et al. Vasomotor menopausal symptoms and risk of cardiovascular disease. Climacteric. 2020;23(6):1–9.

11. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers M, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or menopause? J Am Coll Cardiol. 2009;54(25):2366–2373.

12. Mishra GD, Dobson AJ. Using longitudinal profiles to characterize women's symptoms through midlife. Climacteric. 2012;15(4):369–375.

13. Hodis HN, Mack WJ. Coronary heart disease and hormone replacement therapy after the menopause. Climacteric. 2021;24(3):223–229.